Baby tamoxifen shows promise in preventing breast cancer recurrence
NCT ID NCT06982313
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows up on women who took a low dose of tamoxifen (5 mg daily) for three years to see if it continues to prevent breast cancer over the long term. The original trial found a 42% reduction in breast cancer events. Researchers will also combine data from three similar studies to get stronger evidence. The goal is to confirm that low-dose tamoxifen is a safe and effective prevention option for women with high-risk breast lesions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tamoxifen (low-dose, 5 mg daily)
What this could lead to
If successful, this could confirm that a low dose of tamoxifen is a safe and effective way to prevent breast cancer in women with high-risk breast changes.
What could go wrong
This is a follow-up study, not a new treatment test. The results may not apply to all women, and long-term side effects are still being monitored.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Genova, Italy, 16145, Italy
-
E. O. Ospedali Galliera
Genoa, Italy